A Shanghai-headquartered, globally integrated pharmaceutical R&D leader driving innovation across NCEs, 505(b)(2) pathways, complex generics, and advanced modalities (Peptides & LNPs).
The company's business segments includes: improved Innovative drug development, complex preparation research and development, active pharmaceutical ingredient (API) development, clinical trials for innovative drugs...